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Abstract: Typhoid fever, caused by Salmonella enterica serovar Typhi (S. Typhi), is a global health
concern and its treatment is problematic due to the rise in antimicrobial resistance (AMR). Rapid
detection of patients infected with AMR positive S. Typhi is, therefore, crucial to prevent further
spreading. Clustered Regularly Interspaced Short Palindromic Repeats and CRISPR-associated genes
(CRISPR-Cas), is an adaptive immune system that initially was used for typing purposes. Later, it was
discovered to play a role in defense against phages and plasmids, including ones that carry AMR
genes, and, at present, it is being explored for its usage in diagnostics. Despite the availability of
whole-genome sequences (WGS), very few studied the CRISPR-Cas system of S. Typhi, let alone in
typing purposes or relation to AMR. In the present study, we analyzed the CRISPR-Cas system of
S. Typhi using WGS data of 1059 isolates obtained from Bangladesh, India, Nepal, and Pakistan in
combination with demographic data and AMR status. Our results reveal that the S. Typhi CRISPR
loci can be classified into two groups: A (evidence level >2) and B (evidence level ≤2), in which
we identified a total of 47 unique spacers and 15 unique direct repeats. Further analysis of the
identified spacers and repeats demonstrated specific patterns that harbored significant associations
with genotype, demographic characteristics, and AMR status, thus raising the possibility of their
usage as biomarkers. Potential spacer targets were identified and, interestingly, the phage-targeting
spacers belonged to the group-A and plasmid-targeting spacers to the group-B CRISPR loci. Further
analyses of the spacer targets led to the identification of an S. Typhi protospacer adjacent motif (PAM)
sequence, TTTCA/T. New cas-genes known as DinG, DEDDh, and WYL were also discovered in the S.
Typhi genome. However, a specific variant of the WYL gene was only identified in the extensively
drug-resistant (XDR) lineage from Pakistan and ciprofloxacin-resistant lineage from Bangladesh.
From this work, we conclude that there are strong correlations between variations identified in the S.
Typhi CRISPR-Cas system and endemic AMR positive S. Typhi isolates.
Keywords: Salmonella Typhi; CRISPR diversity; cas genes; antibiotic resistance; Typhi PAM;
spacer targets
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1. Introduction
Typhoid fever is a systemic enteric infection, caused by Salmonella enterica serovar Typhi (S.
Typhi), a human-restricted bacterial pathogen [1,2]. It is estimated to lead to 117 thousand deaths and
11 million episodes of illnesses every year and thus remains a major global public health concern [3].
The fecal–oral transmission route of S. Typhi makes typhoid fever highly endemic in areas with poor
water and sanitation systems, especially the South Asian countries such as Bangladesh, India, Nepal,
and Pakistan [3,4]. Moreover, treating typhoid fever has become harder, because of the increasing
antimicrobial resistance (AMR) [5]. Recently, a highly clonal and extensively drug-resistant (XDR)
lineage of S. Typhi that is resistant to all, but one oral antibiotic, azithromycin, caused a large-scale
typhoid outbreak in Pakistan [6]. A highly ciprofloxacin-resistant lineage (named ‘Bdq’; as a part of
genotype 4.3.1.3, it will be referred to as 4.3.1.3q1 in the rest of the article) has appeared in Bangladesh
and carries a qnr gene-containing plasmid, pK91 [5,7]. Isolates with high azithromycin resistance have
been reported in Bangladesh as well [8,9]. With the availability of whole-genome sequence (WGS)
data, these AMR characteristics can be easily detected and a large amount of WGS data is publicly
available for S. Typhi. WGS data can also shed light on the presence of defense mechanisms that can
recognize and destroy foreign genetic materials [10].
One such system is the Clustered Regularly Interspaced Short Palindromic Repeat and
CRISPR-associated genes (CRISPR-Cas) for which little information is available in S. Typhi [11–14].
A CRISPR locus usually contains two to several hundreds of direct repeat (DR) sequences of 23–50 bp
in length, separated by unique spacer sequences of similar length [15]. Spacers share complementarity
with sequences identified in foreign DNA elements (protospacers) and are acquired from phages,
plasmids, and other transferrable elements that previously infected bacteria [16–18]. To differentiate
foreign DNA elements from self-DNA, the Cas proteins follow often at least three-nucleotide long
protospacer-adjacent motif (PAM) present on the target sequence [19,20].
The genus Salmonella is known to carry a class-1 type I-E system, closely related to the CRISPR-Cas
system in Escherichia coli (E. coli) [21,22]. The systems have been reported to carry either one or two
CRISPR loci and a cas-gene cluster of cas3, cse1-cse2-cas7-cas5-cas6e-cas1-cas2 genes [2,14]. CRISPR-Cas
systems in other bacterial species have been explored extensively for typing purposes [23]. For AMR,
it became evident that the size of the CRISPR loci correlates with the presence or absence of AMR-related
genes [24–27]. In S. Typhi, only a few studies explored the usage of the CRISPR-Cas system for typing
purposes, which is still an unexplored territory [11,12]. Moreover, the earlier studies analyzed only a
smaller number of whole-genome sequences (WGS) to explore the diversity of the system. For example,
Fabre et al. used 18 S. Typhi WGS data to report two different CRISPR loci in the genome (CRISPR1 and
CRISPR2) and used PCR assays to amplify those loci to explore the diversity of DR and spacers [11].
Therefore, an opportunity exists to follow-up this work with a larger set of WGS data to explore the S.
Typhi CRISPR-Cas system further and report on its diversity as well.
In this work, we analyzed the S. Typhi CRISPR-Cas system using WGS data of 1059 isolates
obtained from four major typhoid-endemic countries (Bangladesh, India, Nepal and Pakistan) with the
country of isolation, demographic data, and AMR status. Our work identified potential CRISPR-Cas
system-related markers that associate specifically with endemic and AMR-related S. Typhi isolates.
We further identified unique spacer targets in bacteriophages and plasmids that led to the identification
of a specific PAM sequence for S. Typhi. Next, we annotated common and new cas genes, of which
one, the gene WYL, could be specifically linked to XDR isolates from Pakistan. Collectively, our study
reveals with an impressive dataset that the CRISPR-Cas system in S. Typhi might become of use to
monitor the dissemination of AMR endemic isolates so that their spreading can be contained.
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2. Materials and Methods
2.1. Source and Assembly of the Genome Data
We used published WGS data of 536 isolates from Bangladesh, 198 from Nepal, 131 from India,
and 20 from Pakistan [5,28,29]. These 885 isolates were considered as “Surveillance” cases. WGS data
of 100 isolates from the ongoing XDR S. Typhi outbreak in Pakistan were included and considered as
“Outbreak” cases [6]. Moreover, we included WGS of 74 travel-associated typhoid cases from the UK
who traveled from the four above mentioned countries and categorized them as “Travel” cases [30].
Details of all 1059 cases are provided in Dataset S1. Raw S. Typhi genome data (fastq files) of all cases
were downloaded from the European Nucleotide Archive (ENA), following the accessions given in
source articles. We used SPAdes v3.12.0 (options: cov-cutoff = ’auto’) to assemble the fastq files and
removed smaller contigs (<300 bp) [31]. N50 of the contig files were calculated and added in the
Dataset S1.
To compare the S. Typhi isolates with other Salmonella serovars, we added sequences of 48 complete
chromosomes of 19 different Salmonella serovars (excluding S. Typhi) from NCBI-genome (https:
//www.ncbi.nlm.nih.gov/genome/genomes/152, downloaded on 12 October 2018). We also included
six representative reference genomes of E. coli (https://www.ncbi.nlm.nih.gov/genome/genomes/167,
downloaded on 12 October 2018). Accession numbers of all 54 complete chromosomes of different
Salmonella species/serovars and E. coli isolates are listed in Dataset S2.
2.2. Detection of CRISPR Loci and Cas Genes
To detect the CRISPR loci, we ran all assembled contigs through the CRISPRCasFinder v4.2.19
locally (without the cas-gene option) [32]. Following the earlier reports of S. Typhi DR and spacer length
(29 and 32 bp) [11,21], all DRs and spacers longer than that were checked manually for truncation and
overlap. Identified confirmed loci with an evidence score of 3 or 4 harbored increased numbers of
spacers and were considered as “group-A CRISPR loci”, which is the same as CRISPR1, an earlier
nomenclature used by Fabre et al. [11]. However, unlike previous reports, more than one locus with an
evidence score of 1 or 2 (low number of spacers) were found and all can be compared to CRISPR2
of the earlier nomenclature, thus we considered them as part of the second group of loci, “group-B
CRISPR loci”.
Sequences of direct repeats (DR) and spacers were extracted from all S. Typhi, Salmonella spp.
and E. coli isolates separately and screened for sequence identity within their groups (ignored if
redundant otherwise termed as ‘unique’). All unique DR and spacers were given a unique three-part
identifier (e.g., Td29a, Ts32ac, Ss32aak) following the strategy explained in Figure S1. Spacer
arrangements of all group-A and B CRISPR loci were determined separately.
To detect the cas genes, we used Prokka v1.13.3 (options: gcode = 11) to annotate all 1113 genomes
and blastp v2.7.1 + (options: evalue = 1 × 10−9 and qcov_hsp_perc = 80) to search the annotated protein
sequences against the cas-gene repository published earlier [18,33–35]. For each detected cas-gene,
corresponding nucleotide sequences were extracted from the annotation files and searched against
the contigs using blastn (options: evalue = 1 × 10−9 and qcov_hsp_perc = 95, maximum_bit_score) to
find the gene location (sorted by position in the contigs) and orientation (positive or, negative-strand)
and define the cas-gene loci. The distance from the cas-gene loci to the nearby CRISPR loci was also
calculated. These data were used to visualize the cas-gene loci with nearby CRISPR loci in all S. Typhi
isolates and compare them among themselves. In the case of detected cas-genes of other types of
CRISPR-Cas system than I-E, the length of their coding sequences (CDS) was determined and added
with their gene name (in superscript) to define an identifier for the CDS. An asterisk (*) was added to
all cas genes if its CDS had any non-sense mutation and was interrupted prematurely.
The Supplementary Methods provides details on the collection of epidemiological data, generating
multilocus sequence typing (MLST), genotype and AMR data, conservation of direct repeats (DR),
spacers and their phylogenetic analysis, and finding spacer targets (Doc S1).
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3. Results
3.1. CRISPR Loci of S. Typhi Genomes
A total of 1919 CRISPR loci were detected in the S. Typhi genomes analyzed in this study (Table 1).
Of them, 55% (1054/1919) were group-A and 45% (865/1919) were group-B CRISPR loci. One to even
five CRISPR loci per isolate were detected, but the majority harbored just one (40%) or two (41%)
of them (Figure S2). Bangladeshi surveillance isolates showed a lower range of CRISPR loci per
strain (1–2; 690/536 vs. 2–3; 1229/523) compared to those from other countries (Figure 1a and Table 1).
The extensive drug-resistant (XDR) and non-XDR isolates from the Pakistani outbreak also carried
a relatively lower number of CRISPR loci (2–3; 184 loci from 88 XDR isolates of genotype 4.3.1.1.P1
and 26 loci from 12 non-XDR isolates) (Table 1 and Figure 1a). All other isolates across different study
settings and countries had a higher number of CRISPR loci (1019 loci from 423 isolates) (Figure 1a).
Among the dominant genotypes (with >50 isolates) identified in this study (Table S1), genotype 4.3.1.2
carried the highest average CRISPR loci number (2–3; 509 loci from 213 isolates), whereas the lowest
was for 4.3.1.3 (1–2; 70 loci from 55 isolates) (Table 1 and Figure 1b).
Genes 2020, 11, x FOR PEER REVIEW 4 of 24 
 
  
3.1. ISP  Loci of S. Typhi eno es 
 total of 1919 ISPR loci were detected in the S. Typhi genomes analyzed in this study (Table 
1). Of them, 55% (1054/1919) were group-A and 45% (865/1919) were group-B C ISPR loci. One to 
even five C ISPR loci per isolate were detected, but the majority harbored just one (40%) or t o (41 ) 
of the  (Figure S2). Bangladeshi surveillance isolates showed a lower range of CRISP  loci per strain 
(1–2; 690/536 vs. 2–3; 1229/523) compared to those from other countries (Figure 1a and Table 1). The 
extensive drug-resistant (XDR) and non-XDR isolates from the Pakistani outbreak also carried a 
relatively lower number of CRISPR loci (2–3; 184 loci from 88 XDR isolates of genotype 4.3.1.1.P1 and 
26 loci from 12 non-XDR isolates) (Table 1 and Figure 1a). All other isolates across ifferent stu y 
settings an  co ntries ha  a higher n ber of IS  loci (1019 loci fro  423 isolates) (Fig re 1a). 
ong the dominant genotypes (with >50 isolates) identified in this study (Table S1), genotype 
4.3.1.2 carried the highest average CRISPR loci number (2–3; 509 loci from 213 isolates), whereas the 
lowest was for 4.3.1.3 (1–2; 70 loci from 55 isolates) (Table 1 and Figure 1b). 
 
Figure 1. The number of clustered regularly interspaced short palindromic repeats (CRISPR) loci per 
isolate by (a) different countries and study settings, (b) different genotypes. In both the boxplots, dots 
represent the loci number of the isolates, whereas the blue bar indicates the median CRISPR loci 
number. 
.
(a) different countries and study settings, (b) different genotypes. In both the b xplots,
dots represent the loci number of the isolates, whereas the blue bar indicates th median CRISPR
loci number.
Genes 2020, 11, 1365 5 of 24
Table 1. The number of average CRISPR loci (range) by country and genotype/lineages (all loci numbers are given in “range (median)” format). By country,
Bangladesh-surveillance had the lowest range of CRISPR loci number (1–2). By genotype—4.3.1.1, 4.3.1.3, 4.3.1.3q1, 2.0, 2.3.3, 3.2.2, 3.3.2 and 3.3.2.Bd1 had one locus
per isolate (median).
Different Datapoints Study Type
Surveillance Outbreak Travel Total
Country Bangladesh India Nepal Pakistan Pakistan Bangladesh India Nepal Pakistan -
Total number of Isolates 536 131 198 20 100 38 22 1 13 1059
Total number of CRISPR loci 690 317 457 53 210 102 54 2 34 1919
Range of CRISPR loci 1–2 2–3 2–3 2–3 2–3 2–3 2–3 2-3 2-3 1–2
Number of isolates and
average CRISPR loci
number by genotypes
(genotypes with total
≥10 isolates)
4.3.1
No. of Isolates 15 11 6 4 5 - 5 - 4 50
Loci number 1–2 (1) 2–3 (2) 2–3 (2) 3 (3) 2 (2) - 3–4 (3) - 2–3 (2.5) 2–3 (2)
4.3.1.1
No. of Isolates 223 24 15 7 4 19 2 - 4 298
Loci number 1–2 (1) 2 (2) 2–3 (3) 2–3 (3) 2 (2) 2–3 (3) 2 (2) - 3 (3) 1–2 (1)
4.3.1.1.P1
No. of Isolates - - - - 88 - - - - 88
Loci number - - - - 2–3 (2) - - - - 2–3 (2)
4.3.1.2
No. of Isolates 4 59 133 1 2 1 11 1 1 213
Loci number 1–2 (1) 2–3 (3) 2–3 (2) 2 (2) 2–3 (2.5) 2 (2) 2–3 (2) 2 (2) 2 (2) 2–3 (2)
4.3.1.3
No. of Isolates 53 - - - - 2 - - - 55
Loci number 1–2 (1) - - - - 3 (3) - - - 1–2 (1)
4.3.1.3q1 No. of Isolates 55 - - - - 1 - - - 56
Loci number 1–2 (1) - - - - 3 (3) - - - 1–2 (1)
2.0.0
No. of Isolates 18 1 1 3 - - - - - 23
Loci number 1–2 (1) 2 (2) 2 (2) 2–3 (2) - - - - - 1–2 (1)
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Table 1. Cont.
Different Datapoints Study Type
Surveillance Outbreak Travel Total
Country Bangladesh India Nepal Pakistan Pakistan Bangladesh India Nepal Pakistan -
Number of isolates and
average CRISPR loci
number by genotypes
(genotypes with total
≥10 isolates)
2.2.0
No. of Isolates 3 1 10 - - - - - 1 15
Loci number 1–2 (1) 2 (2) 2 (2) - - - - - 3 (3) 2 (2)
2.3.3
No. of Isolates 18 - - - - 2 - - - 20
Loci number 1–2 (1) - - - - 2–3 (2.5) - - - 1–2 (1)
3.2.2
No. of Isolates 61 2 6 1 - 2 - - 1 73
Loci number 1–2 (1) 2–3 (2.5) 2–3 (1) 3 (3) - 3 (3) - - 3 (3) 1–2 (1)
3.3
No. of Isolates 1 4 3 1 - - - - 1 10
Loci number 3 (3) 2–3 (3) 1 (1) 2 (2) - - - - 2 (2) 2-3 (2)
3.3.2
No. of Isolates 32 1 16 - - 1 - - - 50
Loci number 1–2 (1) 4 (4) 2-3 (2) - - 3 (3) - - - 1–2 (1)
3.3.2.Bd1
No. of Isolates 19 - - - - 2 - - - 21
Loci number 1–2 (1) - - - - 2 (2) - - - 1–2 (1)
3.3.2.Bd2
No. of Isolates 17 - - - - 7 - - - 24
Loci number 1–2 (1) - - - - 2–3 (2) - - - 1–2 (2)
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The maximum likelihood-based phylogenetic tree (MLT) of all group-A CRISPR loci of S. Typhi
showed only one primary clade, whereas the MLT was generated with the group-B CRISPR loci
had subclades specific to their DR sequences (Figure S3a,b). The MLT of all 1919 group-A and B
CRISPR loci showed similar inferences (Figure S4). Surprisingly, 2nd and 3rd group-A CRISPR loci of a
Bangladeshi isolate (accession: ERR2663968) were placed outside the primary clade of the MLT (Figure
S3a). A blastn analysis confirmed this finding by showing a 100% sequence identity with Salmonella
enterica serotype Enteritidis and not S. Typhi.
In the 1919 CRISPR loci, we further identified 15 different DRs, with most having strict specificity
toward a certain CRISPR loci group (Table 2 and Figure S3b). Next, 47 unique spacer sequences were
detected. Most of the spacers (n = 39) showed specificity to either one of the two CRISPR loci groups,
except the four spacers named Ts32c, g, h, i, Ts34a, c, e, and, f (Figure 2 and Table 3) (See Figure S1 for
details about the identifiers of DR and spacers). Among the highly present spacers, Ts32e and l were
only present in group-A loci, whereas Ts55a, Ts54a, and Ts34d showed complete specificity to group-B
CRISPR loci (Figure 2 and Table 3). The MLT of all S. Typhi spacers did not show any clustering for
CRISPR loci group specificity (Figure 2). Instead, group-A and -B CRISPR loci had 7 and 22 different
spacer arrangement patterns, respectively, named as a1-7 and b1-22 (Table 4).
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Table 2. Presence of different S. Typhi DR sequences in different groups of loci by study type and country.
DR UniqueID
All Surveillance(Bangladesh)
Surveillance (India,
Nepal, Pakistan) Surveillance (All) Travel Outbreak
Group-A Group-B Group-A Group-B Group-A Group-B Group-A Group-B Group-A Group-B Group-A Group-B
Td23a 456 3 282 285 72 99
Td28a 1 1 1
Td29a 1054 7 535 3 345 4 880 7 74 100
Td29b 3 2 2 1
Td29c 3 2 2 1
Td34a 1 1 1
Td35a 192 6 148 154 36 2
Td39a 41 19 21 40 1
Td39b 139 117 16 133 6
Td43a 1 1 1
Td49a 3 1 1 2
Td55a 8 1 1 7
Td55b 2 2 2
Td55c 5 5 5
Td55d 3 2 2 1
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Table 3. Presence of different S. Typhi spacer sequences in different groups of loci by study type and country.
Spacer
UniqueID
All Surveillance(Bangladesh)
Surveillance (India,
Nepal, Pakistan) Surveillance (All) Travel Outbreak
Group-A Group-B Group-A Group-B Group-A Group-B Group-A Group-B Group-A Group-B Group-A Group-B
Ts23b 1 1 1
Ts32a 1 1 1
Ts32b 1 1 1
Ts32c 1050 3 531 345 3 876 3 74 100
Ts32d 1 1 1
Ts32e 1050 533 345 876 74 100
Ts32f 1 1 1
Ts32g 1052 2 533 2 345 878 2 74 100
Ts32h 1052 7 533 3 345 4 878 7 74 100
Ts32i 974 2 471 2 332 803 2 71 100
Ts32j 2 2 2
Ts32k 1 1 1
Ts32l 1047 533 342 875 73 99
Ts32m 1 1 1
Ts32n 1 1 1
Ts32o 1 1 1
Ts32p 1 1 1
Ts32q 1 1 1
Ts32r 1 1 1
Ts32s 1 1 1
Ts32t 1 1 1
Ts32u 1 1 1
Ts32v 1 1 1
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Table 3. Cont.
Spacer
UniqueID
All Surveillance(Bangladesh)
Surveillance (India,
Nepal, Pakistan) Surveillance (All) Travel Outbreak
Group-A Group-B Group-A Group-B Group-A Group-B Group-A Group-B Group-A Group-B Group-A Group-B
Ts32w 1 1 1
Ts33a 1 1 1
Ts34a 1 3 3 3 1
Ts34b 1 1
Ts34c 1 2 2 2 1
Ts34d 192 6 148 154 36 2
Ts34e 1 2 2 2 1
Ts34f 1 7 3 4 7 1
Ts34j 1 1 1
Ts36a 4 3 3 1
Ts37a 6 4 4 2
Ts51a 8 1 1 7
Ts51b 3 2 2 1
Ts53a 2 2 2
Ts53b 4 4 4
Ts53c 1 1 1
Ts54a 178 134 37 171 7
Ts54b 1 1 1
Ts54c 1 1 1
Ts55a 454 3 280 283 72 99
Ts55b 1 1 1
Ts55c 1 1 1
Ts59a 3 1 1 2
Ts60a 1 1 1
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Table 4. Different arrangement patterns of the spacers in S. Typhi isolates in this study. Each arrangement
was considered as an “array pattern” and labeled after their loci type with a number (started with “a”
for group-A loci, e.g., a1, a2, etc. and “b” for group-B loci, e.g., b1, b2, etc.).
Loci Group Pattern Names Loci Length (bp) DR Spacer Arrangements
Group-A
a1 517 Td29a Ts32d, Ts32a, Ts32k, Ts32p,Ts32s, Ts32q, Ts32u, Ts32t
a2 * 395, 421, 447, 499 Td29a Ts32h, Ts32c, Ts32l, Ts32e,Ts32i, Ts32g
a3 579 Td29a
Ts32m, Ts32o, Ts32r, Ts32b,
Ts33a, Ts32w, Ts32n,
Ts32f, Ts32v
a4 * 332, 356 Td29a Ts32h, Ts32c, Ts32e,Ts32i, Ts32g
a5 360 Td29a Ts32g, Ts32e, Ts32l,Ts32c, Ts32h
a6 421 Td29a Ts32g, Ts32i, Ts32e, Ts32l,Ts32j, Ts32h
a7 * 273, 299 Td29a Ts32g, Ts32l, Ts32c, Ts32h
Group-B
b1 102 Td23a Ts55a
b2 102 Td23a Ts55b
b3 102 Td23a Ts55c
b4 89 Td29a Ts32h
b5 80 Td28a Ts23b
b6 96 Td29b Ts37a
b7 96 Td29c Ts37a
b8 129 Td34a Ts60a
b9 105 Td35a Ts34d
b10 133 Td39a Ts54a
b11 133 Td39a Ts54c
b12 133 Td39b Ts54a
b13 133 Td39b Ts54b
b14 121 Td43a Ts34j
b15 158 Td49a Ts59a
b16 162 Td55a Ts51a
b17 164 Td55b Ts53a
b18 164 Td55c Ts53b
b19 164 Td55c Ts53c
b20 162 Td55d Ts51b
b21 150 Td29a Ts32c, Ts32h
b22 211 Td29a Ts32g, Ts32i, Ts32h
* Multiple probable deletion events were detected, which caused the variation in the length. In the pattern a2,
most loci had 421 bp length (n = 734), followed by 395 (n = 215), 447 (n = 16) and 499 bp (n = 2).
All group-A CRISPR loci harbored only one consensus DR, Td29a, that were placed in a subclade
with Td35a and Td55b in the MLT of all 15 S. Typhi DRs analyzed (Figure 3). CRISPRmap results
showed Td29a as a member of superclass-B (SeqFamily-F1) with the M1 structure-motif (Table 5).
In contrast, group-B CRISPR loci were dominated by Td23a (53%; 456/885), followed by Td35a (22%;
192/865), Td39b (16%; 139/885), and Td39a (4%; 41/885). Td23a had an M11 structure-motif and
belonged to superclass-B, whereas Td39a and Td39b had another structure-motif, M18 (Table 5).
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3.2. CRISPR Loci of S. Typhi Versus other Salmonella Species
The addition of 91 group-A CRISPR loci from other Salmonella species (84 loci from 48 isolates
of 19 serovars) and E. coli (seven loci from six isolates) to the MLT of all S. Typhi group-A CRISPR
loci (n = 1054) revealed the presence of a primary clade (bootstrap 98) specific for S. Typhi (Dataset
S2 and Figure 4a). The closest neighbor to the clade was S. enterica subsp. enterica (Figure 4a).
This finding obtained further support from the estimated distance (median distance 3.12) calculated
from the multiple sequence alignment (MSA) of all 1145 group-A CRISPR loci (Table S2). The lowest
intra-species distance (mean 0.07) among group-A CRISPR loci was found for S. Typhi (Table S2).
Furthermore, the average length of these CRISPR loci was the shortest among all 19 different Salmonella
serovars studied (after S. enterica Dublin; two isolates) (Table S2). Inside the S. Typhi serovar specific
clade, two small and one large cluster were noticed (100% bootstrap). One small cluster had members
of genotype 3.2.2 and the other had 2.3.3 (ST2209), 3.0.0, and 3.2.1 (mostly ST2) from Bangladesh.
The larger cluster had all other genotypes identified (Figure 4a and Table S1). No other specific
genotype, country-, or MLST-related clustering was identified (Figure 4a).
The MLT of all group-B CRISPR loci did not show exclusive S. Typhi clades but re-illustrated the
DR sequence specificity (Figure 4b). Only three S. Typhi DR sequences (Td35a, Td39a, and Td39b)
showed specificity for the serovar, whereas the subclades of other DR sequences were connected to
other Salmonella species (Figure 4b). MLT of all DR sequences detected in S. Typhi, other Salmonella
spp., and E. coli showed striking sequence similarity to the most dominant S. Typhi DR, Td29a with
five other DR sequences (three from other Salmonella serovars and two from E. coli), and all were
accompanied by high spacer counts (Figure S5a,b).
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Table 5. CRISPRmap results of all the direct repeat (DR) sequences (n = 15) detected from 1059 S. Typhi isolates.
DR Unique
ID
Sequence
Presence in
Number of
Isolates
Presence in
Group-B Loci
Length of
Group-B Loci
CRISPRmap Findings
CRISPRmap ID StructuralMotif
Sequence
Family Sub-Type Superclass
Td23a GCTTCAGTGGCGAACGTCGTGAA 456 456 101 motif 11 - - D
Td28a TTTTGATGTACTTTTGATGTAATTCTGT 1 1 79 - - -
Td29a GTGTTCCCCGCGCCAGCGGGGATAAACCG 1059 7 88, 149, 210 Crod_A_G_10_M1_F1 motif 1 family 1 I-E B
Td29b GTGGGTGGACAGGCTGGACAAAGTGGACA 3 3 95 - - -
Td29c TGTCCACTTTGTCCAGTCTGTCCACCCAC 3 3 95 - - -
Td34a TATATTGGGTGATTACAACTCGTTGAAAAATAAG 1 1 128 - - F
Td35a GTAGACCCTGATCCAGTAGACCCGGTTATCCCTGA 192 192 104 - - -
Td39a CCAGCTTCTGAGCTGCGAATGCGCTGCTGACAGCGGTAC 41 41 132 motif 18 - -
Td39b GTACCGCTGTCAGCAGCGCATTCGCAACTCAGAAGCTGG 139 139 132 motif 18 - -
Td43a TGCGTACCCATCCACCTTTCAGTGCGTACCCATCCACCTTTCA 1 1 120 motif 11 - -
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3.3. Spacers and DRs of S. Typhi
Among the spacers, Ts32i had ubiquitous presence (n = 976) among all study settings, countries,
and genotypes, except for the genotype 3.2.2 (n = 0; p < 0.001). Among others, Ts32c, e, g, h, and l
had a high number of presence among S. Typhi loci (Table 3). The spacer arrangement pattern, a2,
and a5 both presented high specificity (based on presence or absence) to a major non-multidrug
Genes 2020, 11, 1365 15 of 24
resistance (MDR) genotype 3.2.2 (p < 0.001) (Figure 5). Among the dominant spacer patterns, a5
was significantly underrepresented in the MDR or XDR group (p < 0.001), whereas a2 was present
ubiquitously (p < 0.001; Figure S6). The same XDR isolates were also dominated by a combined pattern
of spacer arrangement, a2–b1 (n = 79), however, the pattern was also present in a high number of
non-XDR isolates (Figure S6b,c).
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were almost absent amo g the Bangladesh surveillance isolates (n = 3 and n = 6, respectively), whereas
the latter DR was only identified in two Pakis an outbre k-related isolates (p < 0.001) (Table 2). A few
pairs of spacers and DR sequences (Ts34d-Td35a, Ts55a-Td23a, nd Ts54 -Td39a/b) also showed
specificity to different countries and study settings (p < 0.001) (Table S3 . D taset S3 h s the sequences
of all identified DR and spacers.
3.4. pacer argets and PAM Identification
e thus identifie specific spacers, s, c i e s acer atter s, a -s acer airs f .
yphi that could potentially serve as biomarkers to help identify regional endemicity and AMR amongst
others. Only a few spacers harbored 100% (or, nearly 100%) identity with the bacterial, plasmid,
h ge, viral, and AMR-related sequences (see Doc S1 and Figure S7 for more details and about the
databases and filter settings). For all the obtained spacer target hits, the possible PAM sequences (10 bp
downstream and upstream of the protospacer) were not conserved, except for the spacers targeting t e
plasmid sequences (Figure 6a–e). Indeed, the potential PAM regions of plasmid sequences were highly
conserved and were marked by the motif TTTCA (upstream) and TGCGT (downstream) (Figure 6b).
An almost identical but less conserved motif TTTCT was also observed in the upstre m PAM regio
of the protospacers identified in the phage sequences (Figure 6c). In total, o ly six diff rent spacers
(Ts23b, Ts32a, Ts32g, Ts32i, and Ts32o) harbored protospacers in t e phage sequences, all were s ort
in length (23 or 32 bp), mostly present in group-A loci (Tables 3 and 6). In contrast, five spacers
(Ts34j, Ts53a, Ts53b, Ts53c, and Ts59a) that harbored protospacers in the plasmid sequences showed
specificity to the group-B CRISPR loci and longer in base-pair length (34, 53 or 59 bp) (Tables 3 and 6).
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Each phage-targeting spacer had a different viral target, but none, except Ts32i, targeted a Salmonella
spp. phage (accession: MK268344.1) (Table 6). Ts32i was present in 91% (974/1059) of the isolates
except in genotype 3.2.2 (Table 3). Ts32g was also ubiquitously present (n = 1054) and had a target
against Sinorhizobium phage phiN3 (Tables 3 and 6). In contrast, all plasmid sequences targeted by
the S. Typhi spacers were part of only four different “hypothetical” proteins from either the species
Salmonella enterica or the family Enterobacteriaceae (Table 6). None of these proteins showed any hit in
the Pfam database (https://pfam.xfam.org/).
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Table 6. Detected targets of S. Typhi spacer against the plasmid and phage database. The target-finding
algorithm is illustrated in Figure S7.
Database Spacer Name GenbankAccession Description Size
Phage Ts32a KY006853.1 Erythrobacter phagevB_EliS_R6L 65,675 bp
Phage Ts32g KR052482.1 Sinorhizobium phage phiN3 206,713 bp
Phage Ts32i MK268344.1 Salmonella phage Munch 350,103 bp
Phage Ts32o KY045851.1 Pseudoalteromonas phage C5a 35,209 bp
Phage Ts32o MG592431.1 Vibrio phage1.049.O._10N.286.54.B5
45,021 bp (partial
genome)
Phage Ts32o MG592432.1 Vibrio phage1.050.O._10N.286.48.A6
45,285 bp (partial
genome)
Plasmid Ts34j WP_128853136.1 MULTISPECIES: hypotheticalprotein [Enterobacteriaceae] 72 aa
Plasmid Ts53a WP_053521168.1 hypothetical protein[Salmonella enterica] 62 aa
Plasmid Ts53a WP_071785737.1 hypothetical protein[Salmonella enterica] 59 aa
Plasmid Ts53a WP_071790422.1 hypothetical protein[Salmonella enterica] 76 aa
Plasmid Ts53b WP_053521168.1 hypothetical protein[Salmonella enterica] 62 aa
Plasmid Ts53b WP_071785737.1 hypothetical protein[Salmonella enterica] 59 aa
Plasmid Ts53c WP_053521168.1 hypothetical protein[Salmonella enterica] 62 aa
Plasmid Ts53c WP_071785737.1 hypothetical protein[Salmonella enterica] 59 aa
Plasmid Ts59a WP_053521168.1 hypothetical protein[Salmonella enterica] 62 aa
Plasmid Ts59a WP_071785737.1 hypothetical protein[Salmonella enterica] 59 aa
3.5. Cas Genes
All 1059 S. Typhi isolates had a set of eight cas-genes belonging to the type-I-E CRISPR-Cas
system. Except for five, all (n = 1054) had the same cas locus length, gene arrangement, and orientation
(Figure 7a–c). Among them, 1047 had a group-A CRISPR locus present, 85-87 bp downstream of the cas
gene loci, whereas six had a group-B locus at that location and one had none (Figure 7a–c). Five other
isolates had a non-sense mutation in their cas gene sequence (Figure 7d–f). The isolate (accession:
ERR2663968) with two group-A CRISPR loci had two complete sets of cas genes (the second set is
depicted in Figure 7g). Blastn analysis of the second set of cas genes showed >95% sequence identity
with other Salmonella enterica rather than S. Typhi. The cas genes of the second set were placed outside
the primary clade that contained all other S. Typhi cas genes in the MLTs. Indeed, this is true for all
three MLTs of cas1, cas2, and cas3 genes from S. Typhi, other Salmonella species, and E. coli (Figure
S8a–c). None of the three MLTs showed any high-bootstrap branching either inside that S. Typhi clade,
reflecting a high level of conservation and stability of its cas-loci (Figure S8). However, the presence of a
few other Salmonella species inside the S. Typhi clade was noticed in the case of cas2-MLT (Figure S8b).
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loci found in all 1059 S. Typhi isolates. Each arrow represents a specific cas gene. A stripped arrow
indicates segregation of the cas-loci into two different contigs and the dashed line of the arrow specifies
an interrupted gene. Most of the strains (n = 1047) had a group-A CRISPR downstream of the cas2
gene, six had a group-B locus instead and one strain had none (a–c). cas1 and cas3 genes were split into
two different contigs for two and one strains, respectively (d,e). Another two strains had a non-sense
mutation in the cas1 gene (e,f). The cas3 genes in all cas gene loci were reversely oriented (in comparison
to other cas genes), except for the second cas3 gene identified in ERR2663968. This isolate had two sets
of cas gene loci with almost the same locus lengths (8453 vs. 8454 bp), gene arrangement, but different
sequences (g). However, the length of the two sets of the cas genes in isolate ERR2663968 was different;
cas1 (918 vs. 921 bp), cas6e (705 vs. 651 bp), cas5 (726 vs. 747 bp), cse2gr11 (603 vs. 555 bp), cas8e (1536
vs. 1557 bp), and cas3 (2208 vs. 2664 bp).
In addition to the type-I-E CRISPR-Cas system, all S. Typhi isolates had three copies of DinG,
2–4 copies of DEDDh, and 1–2 copies of WYL genes (Figure S9 and Table S4). All three copies of
DinG and two of the DEDDh genes were completely conserved in all 1059 S. Typhi isolates (Table S4).
Blastn results of a copied variant of the WYL gene, WYL888 (WYL gene of 888 bp length) showed high
sequence identity with a gene that is commonly present on plasmid pK91 (found in S. Typhi genotype
4.3.1.3q1), plasmid-2 of the XDR (genotype 4.3.1.1.P1) isolates from Pakistan and pCTXM-2248 of an
E. coli (accession: MG836696.1) [5–7]. Remarkably, it was only present in genotype 4.3.1.3q1 (100%;
56/56) and 4.3.1.1.P1 (XDR, 86/86) isolates (p < 0.001) (Figure S9 and Table S4), making it a potential
marker for lineage or plasmid identification.
4. Discussion
We here show that S. Typhi isolates can carry up to five different CRISPR loci and about 19%
(203/1059) had three or more CRISPR loci (Figure S2). Al hough previous studies reporte only one or
two loci [2,11,12], they analyzed WGS data of a handful of S. Typhi isolates, a maximum of 18 genomes
by Fabre et al. [1 ], w ich could be the reason why others missed the th rd, fourth, or the fifth loci.
However, these isolates carried only one group-A CRISPR locus with a high spacer count, resembles
CRISPR1 in th previous nomenclatur used by Fab e et al. and it agrees with a few of the previous
ports on the CRISPR-Cas system i S. Typhi [11,12]. Howeve , nearly 40% (422/1059) of our is lates
had only one CRISPR locus and their number was significantly higher among Bangladeshi surveillance
isolates, while the Pakista i outbreak is lates had a relatively lower average loci number (p < 0.001;
Figure 1a and Tab e 1). L c l and highly clonal S. Typhi lineages have be n reported f om both
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countries [5,6] and none of these lineages had higher average numbers of CRISPR loci (Figure 1b).
Hence, clonality could be a contributing factor for the lower number of CRISPR loci identified in
these isolates.
Haplotype specificity of the S. Typhi spacer arrangement patterns has been described [11]. We could
not confirm those associations [11], primarily, because we were unable to identify the same spacers,
except one, Ts32v (match 31/32 bp of a spacer from CRISPR2 described by Fabre et al. [11]). However,
our study revealed multiple spacers (Ts32g, Ts32h, and Ts32i), spacer arrangement patterns (a2 and
a5), DRs (Td23a, Td35a, and Td39a-b), and DR-spacer pairing patterns (Ts34d-Td35a, Ts55a-Td23a,
and Ts54a-Td39a/b) specific to different AMR, country, genotype or surveillance, travel, and outbreak
characteristics (Figures 2, 3 and 5, Tables 2 and 4, Figure S6, Table S3, and Dataset S1). The identified
spacer, DR, and DR-spacer patterns could, therefore, be further exploited by CRISPR-based diagnostic
platforms like SHERLOCK or DETECTR for clinically relevant samples [36,37] to identify AMR among
endemic isolates that are spreading in and beyond South Asian countries [29,38].
The spacer sequences of S. Typhi showed remarkable conservation, and only 47 unique spacers
were detected in 1919 CRISPRs identified in the genomes of 1059 S. Typhi isolates (Table 3 and Dataset
S3). Many spacers in group-A loci (Ts32c, e, g, h, i, and l) were almost universally present in all S. Typhi
isolates, whereas specific spacers (Ts55a, Ts54a, Ts34d) showed high numbers of presence in group-B
loci (Figure 2 and Table 3). Reports on CRISPRs identified in other pathogens described a higher
number of unique spacers, i.e., 2823 spacers from 669 Pseudomonas aeruginosa and 745 from 100 E. coli
isolates [26,39]. In our study, 48 other Salmonella (19 different serovars) and six E. coli isolates showed
857 unique spacers from 136 CRISPR loci and 118 unique spacers from 35 loci identified in their genome,
respectively (data not shown). However, a study of 400 Salmonella enterica isolates of four serovars
(Enteritidis, Typhimurium, Newport, and Heidelberg) reported 179 unique spacers [21]. A lower
number of unique spacers have also been reported for pathogens like Campylobacter jejuni, Neisseria
meningitidis, Pasteurella multocida, Streptococcus agalactiae, and Shigella spp. [40,41]. Such conservative
nature of S. Typhi spacers could be due to host-restriction of S. Typhi.
It is now well established that spacers are likely to share complementarity with a target sequence
(protospacer) in foreign DNA. The S. Typhi CRISPRs have been studied before, but the PAM sequence
was yet to be defined. In our work, we report for the first time a possible PAM sequence, TTTCA/T.
Although this PAM is based on the protospacers of only nine different spacers (Table 6), the nearly
universal presence of two phage-targeting spacers, Ts32g (n = 1054) and Ts32i (n = 976), make this PAM
motif more plausible. Besides that, Ts32i also targets a Salmonella phage suggestive for a functional
CRISPR-Cas-related viral immunity system to protect the S. Typhi genome against bacteriophages.
Furthermore, the differentiation between the spacers or DRs of group-A and -B CRISPR loci were
evident in our work. Very few spacers (n = 8) and DRs (n = 1) were present in both groups and
considering the spacer targets, the S. Typhi group-A CRISPR loci seem more associated with phage
defense, whereas group-B CRISPR loci potentially play a role in the defense against plasmids (Tables 3
and 6). This is not a common finding since the reports of defense mechanisms in other bacterial species
against phages and plasmids are mainly linked to group-A CRISPR loci [42–44].
Similar to the previous reports [11–13], the CRISPR-Cas system identified in our study belongs all
to the type I-E category in the case of S. Typhi. Among the identified cas genes, very few (n = 5) had an
incomplete reading frame (Figure 7), which could be caused by non-sense mutations or sequencing
errors. However, all cas gene loci were detected near a group-A locus, except six, where a group-B locus
was present instead (Figure 7b). Thus, most of the group-B loci can be called “orphan” loci. According
to the CRISPRCasFinder tool, CRISPR loci with low evidence score (which we termed group-B loci)
might be false-positive, but some of the CRISPR arrays can be real. Indeed, the CRISPRCasFinder
tool was specifically designed to identify these types of CRISPR loci so they could be functionally
studied [32]. To our knowledge, orphan loci have never been reported for S. Typhi before. However,
as identified in other prokaryotes, they can exist and even be functional without nearby cas-gene
loci [15,16,18,32,45,46].
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We also identified three different cas genes of other types of CRISPR-Cas system, i.e., DinG,
DEDDh, and WYL (Figure S9 and Table S4). Although the presence of the DinG family helicase gene
suggests an existing type-IV-A CRISPR-Cas system [33], no other cas-genes of that system were found.
No CRISPR loci were present on the same contigs either, but that is not uncommon for this type of
system [16,18]. The type IV-A system is considered as a degraded derivative of class 1 CRISPR-Cas
system, hypothesized to be originating from combinations of mobile genetic elements [16,18,47].
The presence of multiple copies of the WYL gene (part of the type-I system) among the S. Typhi isolates
in our study was interesting, as two copies of this gene, WYL693 and WYL888, had a difference in origin
and presence. The former had a chromosomal match, whereas the latter was probably plasmid-borne
(Table S4). WYL888 matched the plasmid sequences of genotype 4.3.1.3q1 (Bdq lineage) and 4.3.1.1.P1
(XDR lineage) [5–7], making it a potential biomarker for these resistance lineages. However, the role
of WYL888 on these plasmids remains to be elucidated. Remarkably, both the S. Typhi lineages
completely lacked a copy of the DEDDh558 gene (Table S4). Proteins containing the WYL domain
are not uncommon in bacteria and have been reported to regulate transcription of the CRISPR-Cas
systems [48]. The DEDDh gene, on the other hand, has defined exonuclease activity and can fuse
with cas1 and cas2 genes to exert such function [49,50]. The presence of multiple DEDDh domains
in S. Typhi genomes may indicate a compensatory role for the shorter cas3 gene (compared to other
Salmonella species, data not shown), which also functions as an exonuclease.
5. Conclusions
In conclusion, this study is the first large-scale bioinformatic investigation of the S. Typhi
CRISPR-Cas system identified in the genomes obtained from isolates studied in different backgrounds
and four endemic countries. Our results reveal unique conservation and clonality of the S. Typhi type
I-E CRISPR-Cas system, specifically the cas-genes. Despite the clonality of this system, variations were
identified in the type I-E CRISPR-Cas system of S. Typhi that significantly associated with AMR status,
genotypes, demographic origin, and endemic isolates currently circulating in the south Asian countries.
Although no AMR-gene targeting spacers were found, spacers targeting the AMR-containing plasmids
were identified. This indicates a lack of a direct CRISPR-regulated pathway, rather regulating the
AMR-gene acquisition or elimination via controlling the entry of plasmids. Finally, a possible S. Typhi
PAM sequence, TTTCA/T, was defined in this study. Our findings lay a foundation for new genetic and
biochemical experiments to dissect the CRISPR-Cas system of S. Typhi further and gain mechanistic
insights into its molecular function. Overall, the strong correlations of variations identified in the
system with AMR and demographic data of the endemic isolates from south Asian countries should
be investigated further with keeping the development of rapid and inexpensive diagnostic tests as
a target.
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Dataset S1: Complete data of all S. Typhi isolates used in this study, including the ENA accessions, metadata from
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spacer patterns, and presence of newly described cas-genes. Dataset S2: Accession numbers of 48 other Salmonella
(19 different serovars, excluding Typhi) and six E. coli isolates. Dataset S3: Fasta sequence file of all S. Typhi
direct repeats (DR) and spacers identified in this study. Doc S1: Describes the additional parts of the Method and
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different loci were found. Figure S3: Phylogenetic trees of CRISPRs detected in all 1059 S. Typhi isolates in this
study. The trees are based on all detected (a) group-A CRISPR loci (model: TPM2+F+G4) and (b) group-B CRISPR
loci (model: K80+G4) (MDR: Multidrug resistance, XDR: Extensively drug resistant, CIP: ciprofloxacin, DR: Direct
repeats.). Figure S4: Phylogenetic trees of all 1919 group-A and B CRISPR loci detected from 1059 S. Typhi isolates
in this study (model: TVM+FC) (MDR: Multidrug resistance, XDR: Extensively drug resistant, CIP: ciprofloxacin).
Figure S5: (a) Randomly rooted phylogenetic tree of all direct repeat (DR) sequences (n = 69) detected in 1059
S. Typhi, 48 different Salmonella (19 serovars), and six E. coli isolates in this study (model: JC+G4m). The most
common S. Typhi DR sequence, Td29a, and its closely related DRs from other species are highlighted in yellow.
(b) Multiple sequence alignment of closely related DRs from other Salmonella and E. coli of the most dominant S.
Typhi DR, Td29a. Figure S6. Presence of different spacer arrangements (array patterns) among MDR and XDR
isolates. (a) all array patterns of group-A CRISPRs, (b) all array patterns of group-B CRISPRs, c) all array patterns
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of all combined (group-A and B) CRISPR loci. Figure S7: Flow-chart showing the details of spacer-target finding
algorithm. Figure S8: Phylogenetic trees of all S. Typhi, other Salmonella and E. coli isolates in this study, based
on (a) cas1 (model: LG+G4), (b) cas2 (model: LG+G4), and (c) cas3 (model: PROTGAMMAVTF) gene sequences.
Figure S9: Presence of the identified cas genes of other types of CRISPR-Cas system than type-I-E in all 1059
isolates. Each arrow represents a specific cas gene. A stripped arrow indicates the location of the cas-genes into
two different contigs and the dashed line of the arrow specifies an interrupted gene. Except for the DinG*924 and
DinG*1212 variants of the DinG gene, none were located on the same contig. Table S1: Different S. Typhi genotypes
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Typhi based on multiple sequence alignment of all group-A CRISPR loci sequences. Table S3: Presence of multiple
DR-spacer pairs in different genotypes, countries, and study settings. Table S4: Details on different copies of DinG,
DEDDh, and WYL genes. The length of the different copies of the genes was determined and added with their
gene name (in superscript) to define an identifier for the coding sequence (CDS). An asterisk (*) was added to all
cas genes of an isolate if the CDS had any non-sense mutation and interrupted prematurely.
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